About Us

CANCER101 Launches Prescription to Learn®, a Health GPS for Patients & Families.

New York, NY, October 17, 2016: In alignment with the goals of the White House’s Cancer Moonshot Initiative to advance clinical progress, CANCER101 launches Prescription to Learn® (P2L), an interactive platform co-created with patients and caregivers to address the growing problem of information overload. P2L is the “health GPS” to curated resources and solutions to issues patients and caregivers face in navigating health information to make informed decisions. Through P2L, patients and caregivers can personalize their search for information and support, access resources aligned with learning style preference, and view resource ratings from other patients, caregivers, and clinicians.

“‘Where do I start?’ is a question we often hear from newly diagnosed patients and their families, who are inundated with a tsunami of information during a time they need to make life-altering decisions expeditiously,” said Sarah Krug, CEO/Executive Director, CANCER101. “Prescription to Learn was co-created with patients and caregivers to guide them through information from credible sources, allow them to personalize the educational journey based on their preferences, and empower them with the information they need to alleviate fear of the unknown. With answers to their questions and facts at their fingertips, they can focus on what’s most important—their health and well-being. It’s an honor that our collaborative intervention has been highlighted by the White House’s Cancer Moonshot Taskforce, spearheaded by Vice President Joseph Biden, and we are proud to join others in accelerating progress to end cancer as we know it. ”

Developed and launching in partnership with several hospitals, patient advocacy organizations and medical education providers, including University of Texas MD Anderson Cancer Center, Moffitt Cancer Center, Perlmutter Cancer Center at NYU Langone, Mayo Clinic, and the Health Collaboratory, P2L will be available online in four tumor types and expand to eight cancer-specific curriculums in 2017, and will be integrated into medical education curriculum for clinicians nationwide, with plans to expand globally and to other disease states over time. With touch points at over 1,200 hospitals and community practices, hundreds of patient advocacy organizations, and numerous medical education providers, P2L will empower and encourage patients and their caregivers to take control over their diagnosis and partner with their healthcare team to make more informed medical decisions.

CANCER101 is a 501c3 patient advocacy organization established in 2002, whose mission is to empower, inform and engage patients and their caregivers to take control over their diagnosis, navigate the cancer journey, and partner with their healthcare team to make informed decisions. CANCER101 meets cancer patients and their families on the front line and turns a chaotic experience into a calm and organized plan of attack.

Led by Vice President Joseph Biden, the White House Cancer Moonshot Task Force was created “to double the rate of progress in cancer research and treatment, striving to accelerate what could be achieved in ten years in just five.” To date, more than 7,000 individuals—from oncologists to cancer researchers to hospital administrators to survivors—have convened local summits to share information and increase the progression toward a cure. On Monday, October 17, Vice President Biden released the task force’s final report, along with his own Executive Findings after traveling to many of the major nerve centers in the cancer community. He also unveiled a new set of federal actions, private sector actions, and collaborative partnerships to further advance the goals of the Cancer Moonshot Task Force.

Sarah Krüg, CEO/Executive Director, CANCER101
[email protected]